Atlas Trials

Triple Negative

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Triple Negative

RecordFirmDate
A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER) (NCT04333706)University of Southern California2020-09-26
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer (NCT02202746)Clovis Oncology, Inc.2014-09-09

Track Triple Negative automatically

Every clearance here is in the API, with alerts when new ones post.